Lipid management in patients at moderate risk for coronary heart disease: insights from the Air Force/Texas coronary atherosclerosis prevention study (AFCAPS/TexCAPS)
Open Access
- 16 August 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 107 (2), 36-39
- https://doi.org/10.1016/s0002-9343(99)00145-x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Baseline Risk Factors and their Association With Outcome in the West of Scotland Coronary Prevention StudyThe American Journal of Cardiology, 1997
- Cost Effectiveness of Simvastatin Treatment to Lower Cholesterol Levels in Patients with Coronary Heart DiseaseNew England Journal of Medicine, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Cost-Effectiveness of Pravastatin in Secondary Prevention of Coronary Artery DiseaseThe American Journal of Cardiology, 1996
- Cholesterol Lowering and the Use of Healthcare ResourcesCirculation, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible MechanismsNew England Journal of Medicine, 1995
- Cost-effectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart DiseasePublished by American Medical Association (AMA) ,1991